AK1967 (Procizumab)

Procizumab · 4TEEN4 Pharmaceuticals GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK1967 (Procizumab), covering 2025-07-20 to 2025-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab) [Phase 1]